Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi: 10.1172/JCI33816)

Waleed M. Abuzeid, Xiaoling Jiang, Guoli Shi, Hui Wang, David Paulson, Koji Araki, David Jungreis, James Carney, Bert W. O'Malley, Daqing Li

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)4300
Number of pages1
JournalJournal of Clinical Investigation
Volume122
Issue number11
DOIs
StatePublished - Nov 1 2012
Externally publishedYes

Fingerprint

Cisplatin
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi : 10.1172/JCI33816). / Abuzeid, Waleed M.; Jiang, Xiaoling; Shi, Guoli; Wang, Hui; Paulson, David; Araki, Koji; Jungreis, David; Carney, James; O'Malley, Bert W.; Li, Daqing.

In: Journal of Clinical Investigation, Vol. 122, No. 11, 01.11.2012, p. 4300.

Research output: Contribution to journalArticle

Abuzeid, Waleed M. ; Jiang, Xiaoling ; Shi, Guoli ; Wang, Hui ; Paulson, David ; Araki, Koji ; Jungreis, David ; Carney, James ; O'Malley, Bert W. ; Li, Daqing. / Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi : 10.1172/JCI33816). In: Journal of Clinical Investigation. 2012 ; Vol. 122, No. 11. pp. 4300.
@article{558aa4f638b74bf38bdd9710f3aa95c8,
title = "Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi: 10.1172/JCI33816)",
author = "Abuzeid, {Waleed M.} and Xiaoling Jiang and Guoli Shi and Hui Wang and David Paulson and Koji Araki and David Jungreis and James Carney and O'Malley, {Bert W.} and Daqing Li",
year = "2012",
month = "11",
day = "1",
doi = "10.1172/JCI66810",
language = "English (US)",
volume = "122",
pages = "4300",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "11",

}

TY - JOUR

T1 - Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy (Journal of Clinical Investigation (2009) 119, 7, (1974-1985) doi

T2 - 10.1172/JCI33816)

AU - Abuzeid, Waleed M.

AU - Jiang, Xiaoling

AU - Shi, Guoli

AU - Wang, Hui

AU - Paulson, David

AU - Araki, Koji

AU - Jungreis, David

AU - Carney, James

AU - O'Malley, Bert W.

AU - Li, Daqing

PY - 2012/11/1

Y1 - 2012/11/1

UR - http://www.scopus.com/inward/record.url?scp=84868618706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868618706&partnerID=8YFLogxK

U2 - 10.1172/JCI66810

DO - 10.1172/JCI66810

M3 - Article

AN - SCOPUS:84868618706

VL - 122

SP - 4300

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 11

ER -